|
|
Vaccine Detail
|
Influenza A (H1N1) 2009 Monovalent Vaccine from GlaxoSmithKline |
| Vaccine Information |
- Vaccine Name: Influenza A (H1N1) 2009 Monovalent Vaccine from GlaxoSmithKline
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: Influenza A (H1N1) 2009 Monovalent Vaccine
- Manufacturer: GlaxoSmithKline
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA
- Host Species for Licensed Use: Human
- Preservative: Thimerosal
- Allergen: Eggs
- Immunization Route: Intramuscular injection (i.m.)
- Approved Age for Licensed Use: 18 years of age and older
- Description: Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine, indicated for active immunization of adults 18 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus. (FDA: GSK H1N1)
|
| Host Response |
|
|
| References |
FDA: GSK H1N1: FDA: Influenza A (H1N1) 2009 Monovalent Vaccine (GlaxoSmithKline) [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM190377.pdf]
|
|
